News

Brooklyn ImmunoTherapeutics LLC announced it has acquired an exclusive license for mRNA gene editing and cell therapies technology of Factor Bioscience Limited and Novellus Therapeutics…
Read More...

Sirnaomics Biopharmaceuticals (Suzhou) Co. Ltd., a subsidiary of Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against…
Read More...

Catalent, the leading global provider of advanced delivery technologies, development, manufacturing, and clinical supply solutions for drugs, biologics, cell and gene therapies, and…
Read More...

Celltrion Group announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion for the company’s…
Read More...

ADMA Biologics, Inc. an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced that the U.S.…
Read More...

Implandata Ophthalmic Products, a digital health company with offices in Germany and San Diego, California has announced that its game-changing EYEMATE system for digitally enabled…
Read More...

ESSA Pharma Inc. clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced that the Company has entered into a clinical…
Read More...

Toxys and Unilever Safety and Environmental Assurance Centre (SEAC) have entered into an agreement to further validate and expand the ReproTracker assay. Testing for developmental…
Read More...

Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced that their strategic collaboration has taken key steps…
Read More...

GenScript announced the launch of its Research Lentiviral Vector Packaging Service for cell line development, gene editing, and drug discovery. The service enables scientists to package…
Read More...

LogicBio Therapeutics, Inc. a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through…
Read More...

Merck known as MSD outside the United States and Canada, announced that the company has entered into non-exclusive voluntary licensing agreements for molnupiravir with five established…
Read More...

Geneseeq Technology Inc. and AstraZeneca are excited to announce their strategic collaboration to establish a Bio-Diagnostic Innovation Center in Guangzhou, China. The center is…
Read More...

ProBioGen AG announced that Asher Biotherapeutics, Inc., has entered into a service agreement covering all aspects of cell line development, process development and GMP manufacturing at…
Read More...

Mirum Pharmaceuticals, Inc. announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application No. 16/994,368. The…
Read More...

Sanofi has entered into an agreement with Moderna, under which Sanofi will help manufacture Moderna´s COVID-19 vaccine, supporting the COVID-19 pandemic and vaccine supply needs.…
Read More...

AstraZeneca and MSD’s selumetinib has been recommended for conditional marketing authorisation in the European Union (EU) for the treatment of symptomatic, inoperable plexiform…
Read More...

Pieris Pharmaceuticals, Inc. and Boston Pharmaceuticals announced that the companies have entered into an exclusive product license agreement to develop PRS-342, a 4-1BB/GPC3…
Read More...

CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced it has established a multi-year…
Read More...

Samsung Biologics and TG Therapeutics announced an expansion of a large-scale contract manufacturing deal for the supply of TG Therapeutics' ublituximab, an investigational anti-CD20…
Read More...